Latest Comments on Michael Becker's Articles

1. Wall Street Teacher on Buyout Buzz at ASH Hematology Confab: Long and still hopeful on ZIOP. The dilution was painful but... more »
2. jameskildare on Developments for Parkinson's Disease Ignite Investor Enthusiasm: Chronic pain is very severe and this affects people's life, long... more »
3. jimmy Turano on Three Recent Biotech Activist Wins by Carl Icahn: HAPPY THANKSGIVING MIKE BECKER. I THOUGHT SOMEHOW, I COULD REACH... more »
4. Michael Becker on Developments for Parkinson's Disease Ignite Investor Enthusiasm: A comprehensive review of the Parkinson's disease therapeutic... more »
5. Michael Becker on Developments for Parkinson's Disease Ignite Investor Enthusiasm: Thank you. Unfortunately, we did not perform the currency... more »
6. Vitautas on Developments for Parkinson's Disease Ignite Investor Enthusiasm: Mr. Becker! Why you don't mentioned Newron Pharma when you talk... more »
7. maxiedog on Developments for Parkinson's Disease Ignite Investor Enthusiasm: Check your UK pence to USD calculation. 10p is £0.1 not £1. more »
8. 414555 on Healthcare Reform vs Innovation and Growth?: Myth: Police and firefighters retire at age 50 with 90 percent of... more »
9. 414555 on Healthcare Reform vs Innovation and Growth?: Myth: Government pensions are paid by taxpayers. September 23,... more »
10. 414555 on Healthcare Reform vs Innovation and Growth?: > The real waste is retirement of government employees after 30... more »
11. rrbatch on Healthcare Reform vs Innovation and Growth?: I fully agree with the contention that innovation in medicines and... more »
12. advalorem on 11 Ache-Free Investment Opportunities in Neuropathic Pain: Michael, terrific article. Thank you. more »
13. biopharmabull on Bayer's Bold New Bet Fails to Rain on Spectrum Pharma: There is really only one reason for the commercial failure of... more »
14. Michael Becker on Bayer's Bold New Bet Fails to Rain on Spectrum Pharma: Actually, what is making news (and hence, the topic of the... more »
15. User 482664 on Bayer's Bold New Bet Fails to Rain on Spectrum Pharma: article has nothing to do with zevalin being approved for another... more »